| William Lawrence Hagan, MD | |
|
201 S 5th St, Bardstown, KY 40004-1142 | |
| (502) 348-5968 | |
| (502) 349-0963 |
| Full Name | William Lawrence Hagan |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 40 Years |
| Location | 201 S 5th St, Bardstown, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316944556 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 27395 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Intrepid Usa Healthcare Services | Elizabethtown, KY | Home health agency |
| Vna Health At Home | Louisville, KY | Home health agency |
| Caretenders | Elizabethtown, KY | Home health agency |
| Hardin Memorial Hospital | Elizabethtown, KY | Hospital |
| Flaget Memorial Hospital | Bardstown, KY | Hospital |
| Norton Hospitals, Inc | Louisville, KY | Hospital |
| Baptist Health Louisville | Louisville, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baptist Health Medical Group Inc | 5597867184 | 1912 |
| Kentucky Orthopedic Rehabilitation Llc | 0345157293 | 683 |
News Archive
The failure of the U.S. Senate to allow importation of prescription drugs to cut costs, much less the more effective direct bulk purchasing of prescription drugs, is just the latest example of how big industry controls the health reform debate, according to Consumer Watchdog.
Rib-X Pharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel drugs for the treatment of serious multi-drug-resistant infections, announced today it has entered into a further license agreement with Yale University in the area of ribosome and antibiotic structure and function.
An experimental drug combined with an already-popular memory-enhancing compound may further delay memory loss in patients with Alzheimer's disease and other dementias, Johns Hopkins University scientists, in collaboration with researchers from University of North Carolina, have found.
better understand the impact sleep has on medical intern performance, researchers at BWH pioneered two studies both designed to underscore and support efforts hospitals can take to improve patient safety.
Treating prostate cancer with higher doses of proton therapy over a shorter amount of time leads to similar outcomes when compared to standard dose levels and treatments and is safe for patients, according to a new study examining the risk of long-term side-effects from the treatment.
› Verified 7 days ago
| Entity Name | Carefirst Urgent Care Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699725234 PECOS PAC ID: 5193753176 Enrollment ID: O20050801000383 |
News Archive
The failure of the U.S. Senate to allow importation of prescription drugs to cut costs, much less the more effective direct bulk purchasing of prescription drugs, is just the latest example of how big industry controls the health reform debate, according to Consumer Watchdog.
Rib-X Pharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel drugs for the treatment of serious multi-drug-resistant infections, announced today it has entered into a further license agreement with Yale University in the area of ribosome and antibiotic structure and function.
An experimental drug combined with an already-popular memory-enhancing compound may further delay memory loss in patients with Alzheimer's disease and other dementias, Johns Hopkins University scientists, in collaboration with researchers from University of North Carolina, have found.
better understand the impact sleep has on medical intern performance, researchers at BWH pioneered two studies both designed to underscore and support efforts hospitals can take to improve patient safety.
Treating prostate cancer with higher doses of proton therapy over a shorter amount of time leads to similar outcomes when compared to standard dose levels and treatments and is safe for patients, according to a new study examining the risk of long-term side-effects from the treatment.
› Verified 7 days ago
| Entity Name | Hardin Professional Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306894704 PECOS PAC ID: 9739191628 Enrollment ID: O20060614000061 |
News Archive
The failure of the U.S. Senate to allow importation of prescription drugs to cut costs, much less the more effective direct bulk purchasing of prescription drugs, is just the latest example of how big industry controls the health reform debate, according to Consumer Watchdog.
Rib-X Pharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel drugs for the treatment of serious multi-drug-resistant infections, announced today it has entered into a further license agreement with Yale University in the area of ribosome and antibiotic structure and function.
An experimental drug combined with an already-popular memory-enhancing compound may further delay memory loss in patients with Alzheimer's disease and other dementias, Johns Hopkins University scientists, in collaboration with researchers from University of North Carolina, have found.
better understand the impact sleep has on medical intern performance, researchers at BWH pioneered two studies both designed to underscore and support efforts hospitals can take to improve patient safety.
Treating prostate cancer with higher doses of proton therapy over a shorter amount of time leads to similar outcomes when compared to standard dose levels and treatments and is safe for patients, according to a new study examining the risk of long-term side-effects from the treatment.
› Verified 7 days ago
| Entity Name | Baptist Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740586213 PECOS PAC ID: 5597867184 Enrollment ID: O20070228000503 |
News Archive
The failure of the U.S. Senate to allow importation of prescription drugs to cut costs, much less the more effective direct bulk purchasing of prescription drugs, is just the latest example of how big industry controls the health reform debate, according to Consumer Watchdog.
Rib-X Pharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel drugs for the treatment of serious multi-drug-resistant infections, announced today it has entered into a further license agreement with Yale University in the area of ribosome and antibiotic structure and function.
An experimental drug combined with an already-popular memory-enhancing compound may further delay memory loss in patients with Alzheimer's disease and other dementias, Johns Hopkins University scientists, in collaboration with researchers from University of North Carolina, have found.
better understand the impact sleep has on medical intern performance, researchers at BWH pioneered two studies both designed to underscore and support efforts hospitals can take to improve patient safety.
Treating prostate cancer with higher doses of proton therapy over a shorter amount of time leads to similar outcomes when compared to standard dose levels and treatments and is safe for patients, according to a new study examining the risk of long-term side-effects from the treatment.
› Verified 7 days ago
| Entity Name | Baptist Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922401611 PECOS PAC ID: 5597867184 Enrollment ID: O20150219000942 |
News Archive
The failure of the U.S. Senate to allow importation of prescription drugs to cut costs, much less the more effective direct bulk purchasing of prescription drugs, is just the latest example of how big industry controls the health reform debate, according to Consumer Watchdog.
Rib-X Pharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel drugs for the treatment of serious multi-drug-resistant infections, announced today it has entered into a further license agreement with Yale University in the area of ribosome and antibiotic structure and function.
An experimental drug combined with an already-popular memory-enhancing compound may further delay memory loss in patients with Alzheimer's disease and other dementias, Johns Hopkins University scientists, in collaboration with researchers from University of North Carolina, have found.
better understand the impact sleep has on medical intern performance, researchers at BWH pioneered two studies both designed to underscore and support efforts hospitals can take to improve patient safety.
Treating prostate cancer with higher doses of proton therapy over a shorter amount of time leads to similar outcomes when compared to standard dose levels and treatments and is safe for patients, according to a new study examining the risk of long-term side-effects from the treatment.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William Lawrence Hagan, MD 201 S 5th St, Bardstown, KY 40004-1142 Ph: (502) 348-5968 | William Lawrence Hagan, MD 201 S 5th St, Bardstown, KY 40004-1142 Ph: (502) 348-5968 |
News Archive
The failure of the U.S. Senate to allow importation of prescription drugs to cut costs, much less the more effective direct bulk purchasing of prescription drugs, is just the latest example of how big industry controls the health reform debate, according to Consumer Watchdog.
Rib-X Pharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel drugs for the treatment of serious multi-drug-resistant infections, announced today it has entered into a further license agreement with Yale University in the area of ribosome and antibiotic structure and function.
An experimental drug combined with an already-popular memory-enhancing compound may further delay memory loss in patients with Alzheimer's disease and other dementias, Johns Hopkins University scientists, in collaboration with researchers from University of North Carolina, have found.
better understand the impact sleep has on medical intern performance, researchers at BWH pioneered two studies both designed to underscore and support efforts hospitals can take to improve patient safety.
Treating prostate cancer with higher doses of proton therapy over a shorter amount of time leads to similar outcomes when compared to standard dose levels and treatments and is safe for patients, according to a new study examining the risk of long-term side-effects from the treatment.
› Verified 7 days ago
Britta Zoeller Maciuba, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 S 5th St, Bardstown, KY 40004 Phone: 502-348-5968 | |
Hugh Hall Jr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 703 Mcdowell Blvd, Suite 100, Bardstown, KY 40004 Phone: 502-349-1212 Fax: 502-349-1216 | |
Mrs. Lida Miller Oxnard, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 809 Morton Ave Ste 200, Suite 200, Bardstown, KY 40004 Phone: 502-331-0411 Fax: 502-331-0380 | |
Mark Allan Abramovich, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 W John Fitch Ave, Suite 210, Bardstown, KY 40004 Phone: 502-348-7648 Fax: 502-348-7490 | |
Jacob William Vincent, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3615 E John Rowan Blvd Ste 104, Bardstown, KY 40004 Phone: 502-348-5968 Fax: 270-706-5802 | |
Matthew Abel, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3615 E John Rowan Blvd Ste 104, Bardstown, KY 40004 Phone: 502-348-5968 Fax: 270-706-5802 |